Posts with tag R&D

As part of last week’s Spring Budget, the UK Chancellor, Jeremy Hunt, announced increased funding of £10 million for the Medicines and Healthcare Products Regulatory Agency (the MHRA) over the next two years. This funding seeks to support the MHRA in facilitating faster routes for UK-developed medical products to obtain approval and launch on the market where “trusted regulatory partners” have already granted approval outside the UK. Plans in the Spring Budget also indicate a prioritisation of...